Publications by authors named "Aimee Shu"

Claim this Profile
O
Once-Weekly Navepegritide in Children With Achondroplasia: The APPROACH Randomized Clinical Trial.
Ravi Savarirayan, Ciara McDonnell, Carlos A Bacino, Daniel G Hoernschemeyer, Janet M Legare, Aimee D Shu

JAMA Pediatr· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes in Palopegteriparatide-Treated Adults with Hypoparathyroidism: PaTH Forward Trial Extension.
Mishaela Rubin, Andrea Palermo, Tamara Vokes, Aliya A Khan, Peter Schwarz, Aimee D Shu

J Clin Endocrinol Metab· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Once-Weekly Lonapegsomatropin in Adults With Growth Hormone Deficiency: foresiGHt Trial Results.
Beverly M K Biller, Aleksandra Gilis-Januszewska, Mirjana Doknic, Antonio Miguel Pico, Maria Fleseriu, Aimee D Shu

J Clin Endocrinol Metab· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palopegteriparatide in Japanese adults with hypoparathyroidism: 52-week results from the phase 3 PaTHway Japan trial.
Kenji Ashida, Masatoshi Nomura, Noriko Makita, Yasuo Imanishi, Naotetsu Kanamoto, Aimee D Shu

Endocr J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial.
Bart L Clarke, Aliya A Khan, Mishaela R Rubin, Peter Schwarz, Tamara Vokes, Aimee D Shu

J Clin Endocrinol Metab· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Children with Growth Hormone Deficiency Treated with Lonapegsomatropin Demonstrated Sustained Height Improvements for up to 6 Years: enliGHten Trial Final Results.
Aristides K Maniatis, Paul S Thornton, Ulhas M Nadgir, Elpis Vlachopapadopoulou, Oleg Malievskiy, Aimee D Shu

Horm Res Paediatr· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial.
Lars Rejnmark, Elvira O Gosmanova, Aliya A Khan, Noriko Makita, Yasuo Imanishi, Aimee D Shu

Adv Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-weekly TransCon CNP (navepegritide) in children with achondroplasia (ACcomplisH): a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-escalation trial.
Ravi Savarirayan, Daniel G Hoernschemeyer, Merete Ljungberg, Yuri A Zarate, Carlos A Bacino, Aimee D Shu

EClinicalMedicine· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Content validation of the SF-36v2® Health Survey Acute for use in hypoparathyroidism.
Meryl Brod, Laura Tesler Waldman, Aimee D Shu, Alden Smith

Qual Life Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial.
Aliya A Khan, Mishaela R Rubin, Peter Schwarz, Tamara Vokes, Dolores M Shoback, Aimee D Shu

J Bone Miner Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching to Weekly Lonapegsomatropin from Daily Somatropin in Children with Growth Hormone Deficiency: The fliGHt Trial.
Aristides K Maniatis, Ulhas Nadgir, Paul Saenger, Kent L Reifschneider, Jennifer Abuzzahab, Aimee D Shu

Horm Res Paediatr· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Lonapegsomatropin in Children With Growth Hormone Deficiency: enliGHten Trial 2-Year Results.
Aristides K Maniatis, Samuel J Casella, Ulhas M Nadgir, Paul L Hofman, Paul Saenger, Aimee D Shu

J Clin Endocrinol Metab· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Letter to the Editor From Malozowski: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial".
Paul S Thornton, Aristides K Maniatis, Elena Aghajanova, Elena Chertok, Zhengning Lin, Aimee D Shu

J Clin Endocrinol Metab· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Letter to the Editor From L. Sävendahl et al: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial".
Paul S Thornton, Aristides K Maniatis, Elena Aghajanova, Elena Chertok, Elpis Vlachopapadopoulou, Aimee D Shu

J Clin Endocrinol Metab· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism.
Aliya A Khan, Lars Rejnmark, Mishaela Rubin, Peter Schwarz, Tamara Vokes, Aimee D Shu

J Clin Endocrinol Metab· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Average IGF-1 Prediction for Once-Weekly Lonapegsomatropin in Children With Growth Hormone Deficiency.
Zhengning Lin, Aimee D Shu, Mark Bach, Bradley S Miller, Alan D Rogol

J Endocr Soc· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial.
Paul S Thornton, Aristides K Maniatis, Elena Aghajanova, Elena Chertok, Elpis Vlachopapadopoulou, Aimee D Shu

J Clin Endocrinol Metab· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometric validation of the Hypoparathyroidism Patient Experience Scales (HPES).
Meryl Brod, Lori McLeod, Denka Markova, Jill Gianettoni, Sanchita Mourya, Aimee Shu

J Patient Rep Outcomes· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Declining Rates of Inpatient Parathyroidectomy for Primary Hyperparathyroidism in the US.
Sun Moon Kim, Aimee D Shu, Jin Long, Maria E Montez-Rath, Mary B Leonard

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life and hypertension after hormone therapy withdrawal in New York City.
Michelle P Warren, Olivia Richardson, Sonal Chaudhry, Aimee D Shu, Yael Swica

Menopause· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trabecular and cortical microarchitecture in postmenopausal HIV-infected women.
Michael T Yin, Aimee Shu, Chiyuan A Zhang, Stephanie Boutroy, Donald J McMahon

Calcif Tissue Int· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women.
Michael T Yin, Don J McMahon, David C Ferris, Chiyuan A Zhang, Aimee Shu

J Clin Endocrinol Metab· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to osteoporosis medications after patient and physician brief education: post hoc analysis of a randomized controlled trial.
Aimee Der-Huey Shu, Margaret R Stedman, Jennifer M Polinski, Saira A Jan, Minal Patel

Am J Manag Care· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis